erlotinib has been researched along with sb-590885 in 2 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (sb-590885) | Trials (sb-590885) | Recent Studies (post-2010) (sb-590885) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 9 | 0 | 6 |
| 221 | 0 | 180 | 10 | 0 | 8 |
| Protein | Taxonomy | erlotinib (IC50) | sb-590885 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.1934 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, QS; Sun, S; Tang, JF; Wang, XL; Yang, YS; Zhang, F; Zhang, YB; Zhu, HL | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
2 other study(ies) available for erlotinib and sb-590885
| Article | Year |
|---|---|
Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase.
Topics: Binding Sites; Cell Line, Tumor; Cell Proliferation; Dioxanes; Dioxins; Drug Design; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins B-raf; Pyrazoles; Quantitative Structure-Activity Relationship; Quinazolines; Thermodynamics | 2012 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |